v3.26.1
Interim Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue $ 239 $ 494 $ 892 $ 1,519
Cost of revenue 505 529 1,213 1,185
Gross (loss) profit (266) (35) (321) 334
Operating expense:        
Research and development 510 1,016 1,024 1,567
Selling and marketing 1,198 673 1,924 1,001
General and administrative 3,500 2,252 5,916 3,594
Total operating expenses 5,208 3,941 8,864 6,162
Loss from operations (5,474) (3,976) (9,185) (5,828)
Interest expense (30) (144) (66) (197)
Financial income, net 603 211 561 259
Loss before taxes on income (4,901) (3,909) (8,690) (5,766)
Income (tax expense) tax benefit 2 (62) (31) (77)
Net loss (4,899) (3,971) (8,721) (5,843)
Preferred stock dividends:        
Dividend on Series X Preferred Stock (606) (344) (1,229) (344)
Dividend on Series H Preferred Stock (224) (461)
Deemed dividend for down round on Series H Preferred Stock (6,583) (23,556)
Deemed contribution on extinguishment of Series X Preferred Stock 148 3,815 279 3,815
Deemed dividend on modification of Series H Preferred Stock (1,097)
Net loss available to common stockholders $ (12,164) $ (500) $ (34,785) $ (2,372)
Basic net loss available for holders of common stock [1] $ (1.98) $ (1.03) $ (7.37) $ (8.84)
Diluted net loss available for holders of common stock [1] $ (1.98) $ (1.03) $ (7.37) $ (8.84)
Weighted average common stock outstanding [*]        
Weighted average common stock outstanding, basic [1] 6,157,249 484,566 4,717,582 268,389
Weighted average common stock outstanding, diluted [1] 6,157,249 484,566 4,717,582 268,389
Comprehensive loss:        
Net Loss $ (4,899) $ (3,971) $ (8,721) $ (5,843)
Changes in foreign currency translation adjustment (2) (3)
Comprehensive loss available to common stockholders $ (4,899) $ (3,973) $ (8,721) $ (5,846)
[1] Adjusted to reflect the reverse stock splits, see Note 7.